Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1256810-26-0 | MDL No. : | MFCD11846420 |
Formula : | C7H6BrNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KRGGGVKGKFLABG-UHFFFAOYSA-N |
M.W : | 232.03 | Pubchem ID : | 71463965 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 45.39 |
TPSA : | 59.42 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.5 cm/s |
Log Po/w (iLOGP) : | 1.43 |
Log Po/w (XLOGP3) : | 1.71 |
Log Po/w (WLOGP) : | 1.55 |
Log Po/w (MLOGP) : | -0.6 |
Log Po/w (SILICOS-IT) : | 1.41 |
Consensus Log Po/w : | 1.1 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.59 |
Solubility : | 0.591 mg/ml ; 0.00255 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.57 |
Solubility : | 0.62 mg/ml ; 0.00267 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.39 |
Solubility : | 0.954 mg/ml ; 0.00411 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.01 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
81% | With lithium hydroxide monohydrate; water In 1,4-dioxane at 25℃; | A mixture of methyl 6-bromo-3-methoxypicolinate (4 g, 18.4 mmol) and LiOH- H20 (1.6 g, 36.9 mmol) in dioxane / H20 (5 / 1, 40 mL) was stirred at RT overnight. After pH was adjusted to 7, the mixture was filtered to provide crude 6-bromo-3-methoxypicolinic acid (3.1 g, yield: 81 percent). 1H- MR (CDC13 , 400 MHz) δ 10.71 (m, 1H), 7.70 (d, J= 8.0 Hz, 1H), 7.40 (d, J= 8.0 Hz, 1H), 4.01 (s, 3H). MS (M+H)+: 232 / 234. |
[ 321596-58-1 ]
6-Bromo-3-hydroxypicolinic acid
Similarity: 0.93
[ 945954-95-0 ]
6-Bromo-3-methoxypicolinaldehyde
Similarity: 0.91
[ 1060805-13-1 ]
6-Bromo-4-methoxypicolinic acid
Similarity: 0.85
[ 321596-55-8 ]
Methyl 4,6-dibromo-3-hydroxypicolinate
Similarity: 0.85
[ 21190-88-5 ]
Ethyl 6-bromopyridine-2-carboxylate
Similarity: 0.81
[ 945954-95-0 ]
6-Bromo-3-methoxypicolinaldehyde
Similarity: 0.91
[ 1060805-13-1 ]
6-Bromo-4-methoxypicolinic acid
Similarity: 0.85
[ 24059-83-4 ]
Methyl 3-methoxypyridine-2-carboxylate
Similarity: 0.83
[ 321596-58-1 ]
6-Bromo-3-hydroxypicolinic acid
Similarity: 0.93
[ 1060805-13-1 ]
6-Bromo-4-methoxypicolinic acid
Similarity: 0.85
[ 21190-87-4 ]
6-Bromo-2-pyridinecarboxylic acid
Similarity: 0.80
[ 321596-58-1 ]
6-Bromo-3-hydroxypicolinic acid
Similarity: 0.93
[ 945954-95-0 ]
6-Bromo-3-methoxypicolinaldehyde
Similarity: 0.91
[ 1060805-13-1 ]
6-Bromo-4-methoxypicolinic acid
Similarity: 0.85
[ 321596-55-8 ]
Methyl 4,6-dibromo-3-hydroxypicolinate
Similarity: 0.85